Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Heated Rivalry’s season 1 finale honored crew member Sam Willetts with a heartfelt end-credits dedication (Images via Crave and Dignity Memorial) Heated Rivalry wrapped its first season with a soft ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Sagimet Biosciences (SGMT). The reason why I want to go over this biotech next is because just ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is part of a new ...

The European Space Agency has completed the Orion service module for NASA's Artemis 4 mission to the moon, which was saved from cancellation earlier this year by the U.S. Congress When you purchase ...

Rarely has a month gone by in 2025 without OpenAI signing another multibillion-dollar data center deal. In a lengthy post on X on Thursday, OpenAI CEO Sam Altman publicly clarified the totals. “We ...

UroGen is handing an anti-CTLA-4 antibody back to Agenus after concluding phase 1 data for the bladder cancer drug didn’t reach the benchmark for further development. New Jersey-based UroGen forked ...

Saoirse Ronan, Aimee Lou Wood, Anna Sawai and Mia McKenna-Bruce are confirmed to star in Sony Pictures, Sam Mendes and Neal Street’s “The Beatles — A Four-Film Cinematic Event,” the studio announced ...

Pfizer has thrown money at its obesity R&D problem. Having seen its internal assets flounder, the Big Pharma has struck a deal to buy Metsera for an initial $4.9 billion to secure a pipeline of ...

Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what’s been a flurry of acquisitions at a similar price point. Novartis said it was purchasing ...

Novartis AG agreed to buy Tourmaline Bio Inc. in a deal valued at about $1.4 billion as the Swiss drugmaker continues to pursue bolt-on deals to boost its drug pipeline. The company will pay $48 per ...

David Krueger, assistant professor of AI policy and safety at the University of Montreal, labeled the project as incoherent and warned of existential risks, including job losses, societal upheaval, ...